Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Michael J. Dattoli"'
Publikováno v:
Dose-Response, Vol 18 (2020)
Dose-Response
Dose-Response
Many scientists and regulators utilize the linear no-threshold (LNT) relationship to estimate the likelihood of carcinogenesis. The LNT model is incorrect and was adopted based upon false pretenses. The use of the model has been corrupted by many to
Publikováno v:
Journal of Clinical Oncology. 39:231-231
231 Background: Recent studies have shown PVPs to be associated with diminished perioperative and postoperative complications compared to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). This is the first study t
Autor:
Michael J. Dattoli, Daniel Kaplon, Joseph M Kaminski, Stephen Bravo, Alexandria Osorio, David G. Bostwick, Matt Hayes, Patricia M Dycus
Publikováno v:
Journal of Clinical Oncology. 36:186-186
186 Background: Ferumoxytol (Feraheme) is a ferromagnetic nanoparticle with lymphotrophic biokinetics, delivered to lymph nodes by normal macrophages. MRI suppresses normal lymph nodes containing Feraheme. Objective is to validate safety and efficacy
Publikováno v:
Journal of Radiology Nursing. 28:87-95
Prostate cancer can be successfully treated using dynamic adaptive external beam radiation techniques along with interstitial brachytherapy to deliver curative therapies with low urinary, rectal and erectile function morbidity. Through the use of sop
Publikováno v:
Urology. 69:334-337
OBJECTIVES To report the long-term biochemical control rates with brachytherapy-based treatment for patients with prostate cancer at high risk of extracapsular cancer extension. METHODS A total of 243 consecutive patients with at least one higher ris
Autor:
Rudolph Acosta, Jennifer Cash, Michael Binder, Mohendra Biswas, Brent Sullivan, Kent E. Wallner, Michael J. Dattoli, John M. Koval, Douglas Stein, Novelle Kirwan, Lawrence D. True, Richard Sorace, Emilio Lastarria
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 45:853-856
Purpose: To establish the prognostic role of serum enzymatic prostatic acid phosphatase (PAP) in patients treated with palladium ( 103 Pd) and supplemental external beam irradiation (EBRT) for clinically localized, high-risk prostate carcinoma. Metho
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 37:565-569
Purpose: To review post implant morbidity in patients with prior transurethral prostate resection (TURP). Methods and Materials: Nineteen patients with stage T1–T2 prostatic carcinoma and prior TURP were treated with I-125 or Pd-103 implantation fr
Autor:
Richard Sorace, Jennifer Cash, Kent E. Wallner, Michael J. Dattoli, Lawrence D. True, David Bostwick
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2010 (2010)
Journal of Oncology, Vol 2010 (2010)
Background. Perception remains that brachytherapy-based regimens are inappropriate for patients having increased risk of extracapsular extension (ECE).Methods. 321 consecutive intermediate and high-risk disease patients were treated between 1/92 and
Autor:
Joseph Newall, Michael J. Dattoli
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 19:429-433
Although radiation therapy has been universally accepted as the treatment of choice for primary intracranial germinomas, the optimal treatment technique continues to be a matter of controversy. Some authors advocate routine prophylactic craniospinal
Publikováno v:
Cancer. 110(3)
BACKGROUND. This study summarizes long-term outcomes from treatment of prostate cancer with increased risk of extracapsular cancer extension (ECE) using brachytherapy-based treatment. METHODS. A total of 282 consecutive patients were treated from 199